Focal seizure, focal dyskinesia, or both? A complex motor phenomenon reveals anti-NMDAR encephalitis  by Freri, Elena et al.
Seizure 27 (2015) 16–18Clinical letter
Focal seizure, focal dyskinesia, or both? A complex motor phenomenon
reveals anti-NMDAR encephalitis
Elena Freri a, Sara Matricardi a,b, Mara Patrini a, Simona Binelli c, Francesca Andreetta d,
Federica Teutonico e, Nardo Nardocci a, Tiziana Granata a,*
aDepartment of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
bDepartment of Pediatrics, University of Chieti, Chieti, Italy
cClinical Neurophysiology and Epilepsy Center, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
dNeuromuscular Diseases and Neuroimmunology Unit, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
e Child and Adolescence Neuropsychiatry Unit, ‘‘G. Salvini’’ Hospital, Rho, Italy
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eizA R T I C L E I N F O
Article history:
Received 25 October 2014
Received in revised form 31 January 2015
Accepted 5 February 20151. Introduction
Encephalitis associated with anti-N-methyl-D-aspartate-recep-
tor (NMDAR) antibodies is a potentially treatable disease
characterized by the abrupt onset of a constellation of symptoms
resulting from diffuse central nervous system (CNS) dysfunction.
The disease may be associated with ovarian teratoma in young
women, runs a multistage course, and can beneﬁt from early
immunomodulatory treatment [1].
In children, movement disorders (MD) and seizures are
frequently reported to mark the disease onset, nonetheless only
few papers focus on the semiology of these symptoms [2,3].
We report a young girl in whom anti-NMDAR-encephalitis
presented with a complex paroxysmal motor phenomenon, which
combined a focal MD and focal motor seizure.
2. Case report
A 7-year-old girl presented with right-sided focal motor seizures,
while awake. The EEG recorded bilateral delta activity over the
frontal regions, and left frontal sporadic epileptic abnormalities.
Brain magnetic resonance imaging (MRI), performed by epilepsy
protocol, was normal. Carbamazepine was started, but switched
early on to valproate because of seizure persistence. The cerebro-
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following days a complex motor phenomenon, which mainly
involved the right lower limb, appeared.
At our ﬁrst observation, some days after seizure onset, the
neurological examination revealed the presence of continuous
hyperkinesias and a mild dystonic posturing of the lower limbs
more prominent on the right, which impaired walking and
persisted during sleep.
The video-EEG-polygraphy demonstrated that the motor
phenomenon resulted from the combination of MD and seizures:
sub-continuous asymmetric dystonic-hyperkinetic movements of
the lower limbs, not associated with EEG changes (Fig. 1A), were
intermingled with bilateral but asymmetric clonic rhythmic jerks,
more evident on the right. The clonic jerks were time-related with
an ictal discharge starting from vertex and left centro-parietal
region, and spreading to posterior regions (Fig. 1B and Video).
Interictally, the background activity was irregular, with bilateral
high-voltage delta waves over the anterior regions; the sleep
pattern was poorly organized. Focusing on the association of MD
and epileptic seizures, we hypothesized anti-NMDAR-encephalitis.
History recall revealed that insomnia, mood change, loss of
interests and social interaction preceded of a few days the onset of
motor disorder.
Neuropsychiatric evaluation revealed depressive mood, normal
mental abilities (TIQ 106 at the WISC-IV), but deﬁcits in sustained
attention, and in semantic and phonemic verbal ﬂuency.
Anti-NMDAR-antibodies on the previously taken CSF conﬁrmed
the diagnosis; abdominal MRI failed to detect ovarian teratoma.
One month after symptom onset, the girl was given intravenous
pulses of methylprednisolone (20 mg/kg/d for 5 days), followed
by oral prednisone and monthly intravenous immunoglobulins
(IVIG).
Three days after steroid was started, the frequency of
paroxysmal events markedly reduced. The girl was able to walk
unassisted, mood improved, and the wake-sleep cycle regularized.
Twenty days later, while given IVIG, symptoms completely
recovered. The serial video-EEG-polygraphy conﬁrmed the disap-
pearance of paroxysmal symptoms, the progressive reduction of
slow activity and of epileptic abnormalities. In the followingserved.
Fig. 1. EEG during drowsiness: (A) the EMG channels record the subcontinuous movement disorder not associated with EEG changes. (B) the hyperkinesias intermingle with
rhythmic myoclonic jerks at 3.5 Hz, which are associated with a discharge of sharp-waves and slow waves, starting from the vertex and left centro-parietal region (C3-P3, Fz-
Cz), and spreading to the posterior regions of both hemispheres. At seizure end the movement disorder recurs.
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months after the disease onset, the girl was asymptomatic.
The neuropsychiatric re-evaluation revealed normalization of
all cognitive functions, except for mild deﬁcits in phonemic verbal
ﬂuency.
3. Discussion
Anti-NMDAR-encephalitis is increasingly recognized in adults
and children. Disease onset is usually marked by psychiatric
disorders in adults, whereas MD and seizures dominate in children.
MD of different types and severity have been described, including
repetitive and pseudo-rhythmic movements of the limbs, complex
stereotypes (sometimes mimicking voluntary movements), oro-
facial dyskinesias, and dystonic posturing. The coexistence of
different MD in a given patient and their persistence during sleep
are two peculiar features of anti-NMDAR-encephalitis [3].Motor or complex seizures, and epileptic status, are reported in
the early stages particularly in younger patients [1].
In our patient, MD and seizures were strictly focal, involved the
same body segment, and their combination was so tight to result in
an apparently single paroxysmal event. The stereotyped semiology
and the persistence of the symptom during sleep initially led to the
misdiagnosis of focal epilepsy. The video-EEG-polygraphy was of
paramount importance in identifying the coexistence of cortical
and subcortical symptoms, and suggested the diagnosis. The
persistence of dyskinesias during sleep in anti-NMDAR-encepha-
litis have already been described; a possible relation with status
dissociatus has been suggested, given that almost invariably the
sleep pattern becomes destructured in these patients [3].
In its typical presentation, anti-NMDAR-encephalitis is charac-
terized by the association of several neuropsychiatric disorders;
mild or incomplete phenotypes have been only rarely reported
[4]. Although motor symptoms dominated the clinical picture, our
patient was not olygosymptomatic. The careful recall of medical
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sleep and mood disorders preceded the onset of motor phenome-
na. This is in line with previous reports on large series of patients,
which underscore that the majority of patients features at least
four symptoms of the clinical spectrum (seizures, MD, cognitive,
behaviour, psychiatric, and sleep disturbance, autonomic symp-
toms, decrease of consciousness) within four weeks from the onset
[1]. The bilateral anterior delta EEG activity consistently recorded
in our patient and the poor sleep organization gave further
evidence that the brain dysfunction was not limited to the areas
involved in the motor symptoms.
Finally, the dramatic improvement of symptoms observed
after treatment underscores that the rapid recognition of
symptoms may prompt an early diagnosis and targeted treat-
ment. In this respect, it is worth noting that in our patient seizures
and MD did not beneﬁt from AEDs but disappeared after
immunotherapy. This is consistent with the putative inﬂamma-
tory origin of symptoms: B-cell activation and production
of autoantibodies induce internalization and the ensuing reduc-
tion of NMDA-receptors, which in turn may lead to altered
neurotransmission (inactivation of GABAergic neurons, loss of
glutamate homeostasis) and neuronal misﬁring. In this view
restoring receptor functioning is crucial for symptoms recovery.
4. Conclusions
Our case demonstrates that in anti-NMDAR-encephalitis MD
and seizures may be intermingled, and that video-EEG-polygraphyis mandatory in the assessment of complex paroxysmal events.
Non-motor symptoms may be subtle and deserve a focused recall
of medical history. A proper and early treatment may rapidly revert
symptoms.
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